Skip to main content
. 2025 Aug 22;15:30936. doi: 10.1038/s41598-025-16489-1

Table 3.

Associated factors with presence of respiratory symptom.

Associated factors No symptom Symptom Univariable analysis Multivariable analysis (Model 1) Multivariable analysis (Model 2)*
n (%) n (%) Crude OR [95%CI] p-value OR [95%CI] p-value Adjusted OR [95%CI] p-value
Age
0–15 83 (20.0) 331 (80.0) Reference Reference
16–45 199 (39.0) 311 (61.0) 0.39 [0.29–0.53] < 0.001 0.73 [0.51–1.03] 0.08
> 45 45 (34.4) 86 (65.6) 0.48 [0.31–0.74] 0.001 0.90 [0.55–1.48] 0.69
Male gender 176 (36.6) 305 (63.4) 0.61 [0.47–0.79] < 0.001 0.58 [0.43–0.77] < 0.001
Influenza A 1 (0.7) 139 (99.3) 75.75 [10.55–544.08] < 0.001 53.97 [7.41–393.18] < 0.001 53.34 [7.30–389.42] < 0.001
Influenza B 1 (3.8) 25 (96.2)
Respiratory syncytial virus 0 (0) 66 (100)
Metapneumovirus 0 (0) 13 (100)
Adenovirus 4 (25.0) 12 (75.0)
Endemic coronaviruses 14 (29.8) 33 (70.2)

SARS-CoV-2

(N = 741)

5 (35.7) 9 (64.3)
Virus co-infection 2 (7.1) 26 (92.9)
Human rhinovirus 22 (21.4) 81 (78.6) 1.71 [1.05–2.80] 0.03 1.01 [0.54–1.89] 0.98 1.13 [0.60–2.12] 0.70
Haemophilus spp. 149 (26.3) 418 (73.7) 1.56 [1.20–2.03] 0.001 1.03 [0.72–1.47] 0.87 1.03 [0.72–1.49] 0.86
S. pneumoniae 64 (17.5)

301

(82.5)

2.83

[2.08–3.86]

< 0.001

1.90

[1.22–2.94]

0.004

1.90

[1.22–2.98]

0.01
S. aureus 94 (32.6) 194 (67.4) 0.89 [0.66–1.18] 0.41 0.94 [0.63–1.40] 0.75 0.94 [0.63–1.42] 0.78
K. pneumoniae 62 (48.8) 65 (51.2) 0.41 [0.28–0.60] < 0.001 0.53 [0.34–0.83] 0.006 0.58 [0.36–0.92] 0.02
M. catarrhalis 45 (16.4) 230 (83.6) 2.84 [2.01–4.04] < 0.001 1.77 [1.14–2.75] 0.01 1.62 [1.03–2.55] 0.04
B. pertussis 0 (0)

1

(100)

M. pneumoniae 0 (0) 0 (0)
Bacteria co-infection 121 (24.0) 383 (76.0) 1.84 [1.41–2.40] < 0.001 1.14 [0.65–2.01] 0.64 1.10 [0.62–1.96] 0.74
Virus-bacteria co-infection 40 (12.0) 294 (88.0) 4.76 [3.31–6.83] < 0.001 2.69 [1.69–4.29] < 0.001 2.61 [1.62–4.20] < 0.001

*Model 2: adjusted for age and gender of pilgrims.

Influenza B, respiratory syncytial virus, metapneumovirus, adenovirus, human coronaviruses, SARS-CoV-2, virus co-infection, Bordetella pertussis, and Mycoplasma pneumoniae were not included in the analysis because of low prevalence.